Alpinia cearulea (R.Br.) Benth Leaf Extracts Inhibit the Growth of a Panel of Bacterial Pathogens

groupview

Abstract
Pharmacognosy Communications,2018,8,4,146-152.
Published:October 2018
Type:Original Article

Alpinia cearulea (R.Br.) Benth Leaf Extracts Inhibit the Growth of a Panel of Bacterial Pathogens

Lindiwe Nomathemba Mpala1, Getmore Rumbudzai Chikowe1, Ian Edwin Cock1,2,*

1School of Natural Sciences, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

2Environmental Futures Research Institute, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

Abstract:

Introduction: Alpinia caerulea is a perennial herb which grows in coastal regions of Australia. All parts of this species are consumed as a bushfood. Furthermore, A. caerulea is taxonomically related to several plant species with well documented antimicrobial properties. Despite this, A. caerulea leaf solvent extractions have not previously been examined for antibacterial properties. Methods: The antimicrobial activity of A. caerulea leaf solvent extractions was investigated by disc diffusion and growth time course assays against a panel of pathogenic bacteria. The growth inhibitory activity was quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: Methanolic and aqueous A. caerulea leaf extracts inhibited the growth of a range of gram positive and gram negative bacterial species. The methanolic extract was generally a more potent growth inhibitor than the aqueous extract. The methanolic and aqueous extracts were particularly potent inhibitors of S. marcenscens growth, with MIC values as low as 188 μg/mL for the methanolic extract. P. mirabilis (MICs of 785 and 976 μg/mL for the methanolic and aqueous extracts respectively) and K. pneumoniae growth (MICs of 1167 and 924 μg/mL for the methanolic and aqueous extracts respectively) were also particularly susceptible to the A. caerulea leaf extracts. The antibacterial activity of the methanolic and aqueous A. caerulea leaf extracts was further investigated by growth time course assays which showed significant growth inhibition in cultures of S. marcenscens and P. mirabilis within 1 h of exposure. All extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for internal use as well as for topical uses. Conclusion: The lack of toxicity of the A. caerulea leaf extracts and their growth inhibitory bioactivity against a panel of pathogenic bacteria indicate their potential in the development of antibiotic agents.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.